Particularly encouraging to the South San Francisco-based pharmaceutical giant were sales of its cancer-fighting drug Avastin, which soared 33% for the quarter to $564 million. Long-range, Genentech raised its full-year profit outlook to a range of $2.85 per share to $2.95 per share, ...
Of course, many larger pharmaceutical companies are also working on treatments for various types of cancer, but it's always easy to find information on those. Additionally, small-cap stocks can offer attractive returns compared to large caps, although the possibility of robust returns also comes w...
For investors, small-cap stocks can be a great idea. They offer an opportunity for massive growth potential that can often outpace even a blue-chip stock. Small-cap stocks have relatively low market capitalization, ranging from several hundred million to $1 billion and more. If one of the...
Our screen of the Street's best small-cap stocks served up a list dominated by the healthcare sector, mostly pharmaceutical and biotechnology companies. That's to be expected, and investors should always do their own due diligence when considering, say, a clinical-stage biotech firm, whic...
StocksTheStreet.com RatingsInvesting By TheStreet Ratings Start Conversation TheStreet Daily Newsletter Sign up today for our free newsletter and you'll receive an exclusive report explaining hedge fund guru Doug Kass' winning investment style.
Friday's Small-Cap Winners & Losers CKX surges on a deal to take the company private. Sarina Penn Jun 1, 2007 4:03 PM EDTStart Conversation Small-cap stocks outperformed the broader market amid takeout news and positive analyst research. CKX (CKXE) , which holds image rights to ...
Health Stocks Slide as Trump Picks Vaccine Skeptic Kennedy(Bloomberg) — Pharmaceutical stocks slumped as President-elect Donald Trump said he’s tapping Robert F. Kennedy …Continue ReadingHealth Stocks Slide as Trump Picks Vaccine Skeptic Kennedy ...
Stocks to Watch: LUNR NRDY BE ZONE NVDA WKHS XPEV Alex Carlson November 17, 2024 Medcana (SFWJ) Snags Aussie Revs with Pharmaceutical Grade Cannabis Jarrod Wesson November 7, 2024 Galectin Therapeutics (NASDAQ: GALT): Disrupting Merck’s Cancer Dominance ...
From a universe of Japanese stocks with market capitalization in the bottom 20%, the Hennessy Japan Small Cap Fund seeks companies with time-tested business models and exceptional management trading at attractive valuations. Focusing on sustainable growth while limiting the downside, the Portfolio Manage...
See Congress Small Cap Growth Fund (CSMCX) mutual fund ratings from all the top fund analysts in one place. See Congress Small Cap Growth Fund performance, holdings, fees, risk and other data from Morningstar, S&P, and others.